Terns Pharmaceuticals Inc. (TERN)
52.95
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 15-12G Terns Pharmaceuticals,
May 15, 2026 9:01 AM - SEC Filing
Form SCHEDULE 13G/A Terns Pharmaceuticals, Filed by: Adage Capital Management, L.P.
May 13, 2026 9:19 AM - SEC Filing
Form SCHEDULE 13G/A Terns Pharmaceuticals, Filed by: MORGAN STANLEY
May 12, 2026 11:11 AM - SEC Filing
Form EFFECT Terns Pharmaceuticals,
May 8, 2026 6:09 AM - SEC Filing
Form 4 Terns Pharmaceuticals, For: May 05 Filed by: Azelby Robert
May 5, 2026 5:08 PM - SEC Filing
Form 4 Terns Pharmaceuticals, For: May 05 Filed by: Turner Heather D
May 5, 2026 5:07 PM - SEC Filing
Form 4 Terns Pharmaceuticals, For: May 05 Filed by: Tripuraneni Radhika
May 5, 2026 5:06 PM - SEC Filing
Form 4 Terns Pharmaceuticals, For: May 05 Filed by: Quigley Jill M.
May 5, 2026 5:05 PM - SEC Filing
Form 4 Terns Pharmaceuticals, For: May 05 Filed by: KINDLER JEFFREY B
May 5, 2026 5:04 PM - SEC Filing
Form 4 Terns Pharmaceuticals, For: May 05 Filed by: FELLOWS DAVID A
May 5, 2026 5:03 PM - SEC Filing
Form 4 Terns Pharmaceuticals, For: May 05 Filed by: Kuriakose Emil
May 5, 2026 5:02 PM - SEC Filing
Form 4 Terns Pharmaceuticals, For: May 05 Filed by: Gengos Andrew
May 5, 2026 5:01 PM - SEC Filing
Form 4 Terns Pharmaceuticals, For: May 05 Filed by: Burroughs Amy L.
May 5, 2026 5:00 PM - SEC Filing
Form S-8 POS Terns Pharmaceuticals,
May 5, 2026 10:10 AM - SEC Filing
Form S-8 POS Terns Pharmaceuticals,
May 5, 2026 10:07 AM - SEC Filing
Form S-8 POS Terns Pharmaceuticals,
May 5, 2026 10:05 AM - SEC Filing
Form S-8 POS Terns Pharmaceuticals,
May 5, 2026 10:03 AM - SEC Filing
Form S-8 POS Terns Pharmaceuticals,
May 5, 2026 10:01 AM - SEC Filing
Form S-8 POS Terns Pharmaceuticals,
May 5, 2026 9:58 AM - SEC Filing
Form S-8 POS Terns Pharmaceuticals,
May 5, 2026 9:56 AM - SEC Filing
Form S-8 POS Terns Pharmaceuticals,
May 5, 2026 9:54 AM - SEC Filing
Form S-8 POS Terns Pharmaceuticals,
May 5, 2026 9:51 AM - SEC Filing
Form POS AM Terns Pharmaceuticals,
May 5, 2026 9:47 AM - SEC Filing
Form POSASR Terns Pharmaceuticals,
May 5, 2026 9:44 AM - SEC Filing
Form 8-K Terns Pharmaceuticals, For: May 05
May 5, 2026 9:22 AM - SEC Filing
Form SC 14D9/A Terns Pharmaceuticals, Filed by: Terns Pharmaceuticals, Inc.
May 5, 2026 9:16 AM - SEC Filing
Form 25-NSE Terns Pharmaceuticals, Filed by: Nasdaq Stock Market LLC
May 5, 2026 8:57 AM - SEC Filing
Form SC TO-T/A Terns Pharmaceuticals, Filed by: Merck & Co., Inc.
May 5, 2026 8:53 AM - SEC Filing
Merck completes $5.8 billion acquisition of Terns Pharmaceuticals
May 5, 2026 8:45 AM - StreetInsider
Merck Completes Acquisition of Terns Pharmaceuticals, Inc.
May 5, 2026 8:45 AM - BizWire
Form 10-K/A Terns Pharmaceuticals, For: Dec 31
April 27, 2026 4:19 PM - SEC Filing
Form 8-K Terns Pharmaceuticals, For: Apr 27
April 27, 2026 8:10 AM - SEC Filing
Terns Pharmaceuticals receives FDA breakthrough designation for TERN-701
April 27, 2026 8:05 AM - StreetInsider
Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia
April 27, 2026 8:05 AM - Globe NewsWire
Oppenheimer Downgrades Terns Pharmaceuticals (TERN) to Perform
April 27, 2026 12:55 AM - StreetInsider
Form SC 14D9/A Terns Pharmaceuticals, Filed by: Terns Pharmaceuticals, Inc.
April 24, 2026 8:11 AM - SEC Filing
Form SC TO-T/A Terns Pharmaceuticals, Filed by: Merck & Co., Inc.
April 24, 2026 7:31 AM - SEC Filing
Merck clears HSR waiting period for $53 per share Terns acquisition
April 24, 2026 6:45 AM - StreetInsider
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.
April 24, 2026 6:45 AM - BizWire
Leerink Partners Downgrades Terns Pharmaceuticals (TERN) to Market Perform
April 8, 2026 9:59 AM - StreetInsider
Mizuho on Terns Pharmaceuticals (TERN): current MRK deal represents 'excellent outcome' for TERN shareholders
April 8, 2026 9:54 AM - StreetInsider
Increasing unusual call option volume: TERN IVZ PTEN HTZ PRGO CAR SCO SLNO
April 8, 2026 4:18 AM - StreetInsider
Form SC 14D9 Terns Pharmaceuticals, Filed by: Terns Pharmaceuticals, Inc.
April 7, 2026 12:47 PM - SEC Filing
Form SC TO-T Terns Pharmaceuticals, Filed by: Merck & Co., Inc.
April 7, 2026 12:43 PM - SEC Filing
William Blair Downgrades Terns Pharmaceuticals (TERN) to Market Perform
April 7, 2026 12:20 PM - StreetInsider
Increasing unusual option volume: TERN CORN IVZ ATLX SPCE
April 7, 2026 9:42 AM - StreetInsider
Merck launches tender offer to acquire Terns Pharmaceuticals for $53 per share
April 7, 2026 9:38 AM - StreetInsider
Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc.
April 7, 2026 9:38 AM - BizWire
Merck launches tender offer to acquire Terns Pharmaceuticals for $53 per share
April 7, 2026 9:04 AM - StreetInsider
Shareholder Alert: Ademi LLP investigates whether Terns Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders
April 7, 2026 6:53 AM - StreetInsider
Form 4 Terns Pharmaceuticals, For: Apr 01 Filed by: Kuriakose Emil
April 2, 2026 6:16 PM - SEC Filing
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
April 2, 2026 4:05 PM - StreetInsider
William Blair Shuffles Analyst Conviction List for April 2026
April 1, 2026 7:15 AM - StreetInsider
Form S-8 Terns Pharmaceuticals,
March 30, 2026 5:56 PM - SEC Filing
Form 10-K Terns Pharmaceuticals, For: Dec 31
March 30, 2026 5:36 PM - SEC Filing
Truist Securities Downgrades Terns Pharmaceuticals (TERN) to Hold
March 30, 2026 4:31 PM - StreetInsider
Barclays Downgrades Terns Pharmaceuticals (TERN) to Equalweight
March 30, 2026 3:03 AM - StreetInsider
Form SCHEDULE 13G/A Terns Pharmaceuticals, Filed by: VANGUARD GROUP INC
March 27, 2026 1:33 PM - SEC Filing
Mizuho Downgrades Terns Pharmaceuticals (TERN) to Neutral on Merck acquisition
March 27, 2026 8:50 AM - StreetInsider
BMO Capital Downgrades Terns Pharmaceuticals (TERN) to Market Perform
March 26, 2026 4:06 PM - StreetInsider
Form SC TO-C Terns Pharmaceuticals, Filed by: MERCK SHARP & DOHME LLC
March 26, 2026 6:07 AM - SEC Filing
Increasing unusual call option volume: TERN ORBS REAL VGZ DOC BZAI TXG TWO AIRS FSK
March 26, 2026 6:05 AM - StreetInsider
Increasing unusual option volume: TERN RXT REAL ORBS HDB PD BWA VGZ
March 26, 2026 6:05 AM - StreetInsider
Citizens Downgrades Terns Pharmaceuticals (TERN) to Market Perform
March 26, 2026 3:39 AM - StreetInsider
Form SC14D9C Terns Pharmaceuticals, Filed by: Terns Pharmaceuticals, Inc.
March 25, 2026 5:09 PM - SEC Filing
Form SC TO-C Terns Pharmaceuticals, Filed by: MERCK SHARP & DOHME LLC
March 25, 2026 4:50 PM - SEC Filing
TD Cowen Downgrades Terns Pharmaceuticals (TERN) to Hold
March 25, 2026 4:09 PM - StreetInsider
Terns Pharmaceuticals Inc. (TERN)
March 25, 2026 10:32 AM - StreetInsider
Mizuho on Terns Pharmaceuticals (TERN): MRK acquisition 'makes sense on multiple levels'
March 25, 2026 10:18 AM - StreetInsider
H.C. Wainwright Downgrades Terns Pharmaceuticals (TERN) to Neutral
March 25, 2026 10:13 AM - StreetInsider
Truist Securities stays Buy on Terns Pharmaceuticals (TERN) as Merck acquires 'for a steal'
March 25, 2026 8:12 AM - StreetInsider
Form SC14D9C Terns Pharmaceuticals, Filed by: Terns Pharmaceuticals, Inc.
March 25, 2026 7:52 AM - SEC Filing
Form SC TO-C Terns Pharmaceuticals, Filed by: MERCK SHARP & DOHME LLC
March 25, 2026 7:30 AM - SEC Filing
Form 8-K Terns Pharmaceuticals, For: Mar 24
March 25, 2026 7:18 AM - SEC Filing
Merck to buy oncology firm Terns Pharmaceuticals in $6.7 billion deal
March 25, 2026 7:02 AM - StreetInsider
Terns Pharmaceuticals Inc. (TERN) call put ratio 1 call to 1.2 puts into Merck (MRK) to acquire
March 25, 2026 7:00 AM - StreetInsider
Merck to acquire Terns Pharmaceuticals for $6.7 billion
March 25, 2026 6:45 AM - StreetInsider
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)
March 25, 2026 6:45 AM - BizWire
Merck (MRK) Nears $6b Deal To Buy Terns Pharma (TERN) - FT
March 24, 2026 9:20 PM - StreetInsider
Form 4 Terns Pharmaceuticals, For: Mar 16 Filed by: Burroughs Amy L.
March 17, 2026 6:10 PM - SEC Filing
Increasing unusual call option volume: PSA TERN IRM ADMA HIMX MRK BCE BNO GROY
March 16, 2026 5:38 AM - StreetInsider
Increasing unusual option volume: TERN XLB BKLN GROY HIMX BIZD ADMA
March 13, 2026 11:18 AM - StreetInsider
Full Article List
